Amgen earnings beat expectations
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Deckers earnings beat analyst expectations
Goleta-based footwear and apparel company Deckers Brands reported an 8 percent increase in its second quarter revenue Oct. 24, beating analyst expectations with $2.71 in earnings per share. The company also announced the appointment of a new chairman to its board of directors, board member and former CFO of Coach Inc., Mike Devine. Former chairman Read More →
Teledyne shares soar as earnings beat estimates
Shares of Thousand Oaks-based Teledyne Technologies jumped nearly 6 percent or $18 on Oct. 23 after the company reported quarterly results that beat estimates. Teledyne shares were trading in the $330 range in afternoon trading after the company reported adjusted earnings of $2.57 per share and revenue of $802.20 million for the quarter ended September Read More →
Amgen declares fourth-quarter dividend
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Bank of the Sierra reports third quarter earnings
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
LTC Properties declares monthly cash dividend
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sienna Biopharmaceuticals filing for Chapter 11 bankruptcy
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
